MEG3 and Duchenne muscular dystrophy: Collectively, these results indicate that lncRNA‐MEG3 attenuates fat infiltration‐induced oxidative stress and inflammatory responses, highlighting its therapeutic potential in treating muscle degenerative diseases such as DMD.